Nature13y
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function
Immunofluorescence was performed on OB differentiated on culture slides (BD Biosciences, California) for 2 weeks in the presence or absence of CCL3, media was changed twice weekly. Cells were then ...